Results 21 to 30 of about 102,448 (289)

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force [PDF]

, 2013
Background: Therapeutic targets have been defined for diseases like diabetes, hypertension or rheumatoid arthritis and adhering to them has improved outcomes. Such targets are just emerging for spondyloarthritis (SpA). Objective: To define the treatment
Baraliakos, Xenofon, Betteridge, Neil, Braun, Jürgen, Burgos-Vargas, Ruben, Collantes-Estevez, Eduardo, de Wit, Martinus, Deodhar, Atul, Dougados, Maxime, Elewaut, Dirk, Emery, Paul, FitzGerald, Oliver, Gossec, Laure, Helliwell, Philip, Jongkees, Merryn, Kavanaugh, Arthur, Kvien, Tore K, Landewé, Robert, Luger, Thomas, Maccarone, Mara, Mease, Philip, Olivieri, Ignazio, Redlich, Kurt, Reveille, John, Ritchlin, Christopher, Rudwaleit, Martin, Schoels, Monika, Sieper, Joachim, Smolen, Josef S, Van den Bosch, Filip, van der Heijde, Désirée, Wei, James Cheng-Chung, Winthrop, Kevin   +31 more
core   +2 more sources

Tumor necrosis factor inhibitors in psoriatic arthritis. [PDF]

, 2017
INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can result in significant disability. With the emergence of tumor necrosis factor inhibitors (TNFi), therapeutic outcomes in PsA have improved substantially.
Kraft, Walter K., Mantravadi, Santhi, Ogdie, Alexis   +2 more
core   +2 more sources

Ankylosing Spondylitis

Journal of Ophthalmic and Vision Research, 2021
The seronegative spondyloarthropathies are a group of autoimmune inflammatory diseases lacking rheumatoid factor or antinuclear antibody in their serum. They include ankylosing spondylitis (AS), reactive arthritis, psoriatic arthritis, spondylitis associated with Crohn’s disease and ulcerative colitis, and undifferentiated spondyloarthropathies ...
Nazanin Ebrahimiadib, Sahar Berijani, Mohammadreza Ghahari, Fatemeh Golsoorat Pahlaviani   +3 more
openaire   +4 more sources

Evaluation of serum paraoxonase and arylesterase activities in ankylosing spondylitis patients

Clinics, 2010
OBJECTIVES: The aim of this study was to investigate the activities of serum paraoxonase and arylesterase in patients with ankylosing spondylitis with respect to those of healthy controls, to assess whether these enzyme levels are related to disease ...
Fazile Hatipoglu Erdem, Saliha Karatay, Kadir Yildirim, Ahmet Kiziltunc   +3 more
doaj   +1 more source

Physical activity and sedentary behaviour and their associations with clinical measures in axial spondyloarthritis [PDF]

, 2019
Engaging in physical activity (PA) is a key aspect in the management of axial spondyloarthritis (axial SpA), however, its relationship with clinical measures is unknown.
Cameron, Sara, Coulter, Elaine, McDonald, Marie Therese, Paul, Lorna, Siebert, Stefan   +4 more
core   +3 more sources

Ankylosing spondylitis

Wiener Medizinische Wochenschrift, 2010
Ankylosing Spondylitis (AS) is an autoimmune disease of unknown cause belonging to the group of spondyloarthritides associated with HLA B27. This disease affects the spine and sacroiliac joints, but may also concern peripheral joints and different organs. Symptoms include morning stiffness and dull low back pain, both improving by exercise.
Jeanette, Wolf, Peter, Fasching
openaire   +6 more sources

Ankylosing Spondylitis: a trade Off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia [PDF]

, 2019
The frequency of HLA-B27 in patients with Ankylosing Spondylitis (AS) is over 85%. There are more than 170 recognized HLA-B27 alleles but the majority of them is not sufficiently represented for genetic association studies.
Cauli, A, Fiorillo, Mt, Mathieu, A, Paladini, F, Sorrentino, R., Tedeschi, V   +5 more
core   +2 more sources

Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis

BMC Musculoskeletal Disorders, 2007
Background Ankylosing spondylitis is a chronic inflammatory rheumatic disorder which usually begins in early adulthood. The diagnosis is often delayed by many years.
Hodler Juerg, Kissling Rudolf O, Pfirrmann Christian WA, Weber Ulrich, Zanetti Marco   +4 more
doaj   +1 more source

Patient perspectives of managing fatigue in ankylosing spondylitis, and views on potential interventions: a qualitative study [PDF]

, 2013
<p>Background: Fatigue is a major component of living with ankylosing spondylitis (AS), though it has been largely over-looked, and currently there are no specific agreed management strategies.</p> <p>Methods: This qualitative ...
A Calin, A van Tubergen, B Belza, D Cote-Arsenault, E Dernis-Labous, Elizabeth Irvine, H Dagfinrud, H Repping-Wuts, Helen Davies, J Kabat-Zinn, J Kabat-Zinn, J Trendall, KGA Adams, MD Atkinson, MG Swain, Michael Dennis, MM Ward, MP Davis, N Aissaoui, National Institute for Health and Clinical Excellence, P Burnard, P Grossman, R Gunaydin, RE Boyatzis, Roxanne Cooksey, S Brophy, S Council:, S Garrett, S Hewlett, S Hultgren, SC Richards, SD Jones, SDH Brophy, Sinead Brophy, Stefan Siebert, Welsh Assembly Government, WH Koh, Y Ibn Yacoub, Y Turan   +38 more
core   +2 more sources

Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis

Genome Biology, 2017
Background The assessment and characterization of the gut microbiome has become a focus of research in the area of human autoimmune diseases. Ankylosing spondylitis is an inflammatory autoimmune disease and evidence showed that ankylosing spondylitis may
Chengping Wen, Zhijun Zheng, Tiejuan Shao, Lin Liu, Zhijun Xie, Emmanuelle Le Chatelier, Zhixing He, Wendi Zhong, Yongsheng Fan, Linshuang Zhang, Haichang Li, Chunyan Wu, Changfeng Hu, Qian Xu, Jia Zhou, Shunfeng Cai, Dawei Wang, Yun Huang, Maxime Breban, Nan Qin, Stanislav Dusko Ehrlich   +20 more
doaj   +1 more source